awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35829430-6F77B8FB-5D51-4E26-8131-3BB505519DB9
Q35829430-6F77B8FB-5D51-4E26-8131-3BB505519DB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35829430-6F77B8FB-5D51-4E26-8131-3BB505519DB9
Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.
P2860
Q35829430-6F77B8FB-5D51-4E26-8131-3BB505519DB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35829430-6F77B8FB-5D51-4E26-8131-3BB505519DB9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d9c05773f3bd158cdc761d09afd431901d92767
P2860
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.